Unveiling metabolic remodeling in mucopolysaccharidosis type III through integrative metabolomics and pathway analysis

about

Unveiling metabolic remodeling in mucopolysaccharidosis type III through integrative metabolomics and pathway analysis

Item

http://www.wikidata.org/entity/Q58765604

description

scientific article published on 04 September 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Unveiling metabolic remodeling ...... abolomics and pathway analysis

@en

Unveiling metabolic remodeling ...... abolomics and pathway analysis

@nl

type

Item

label

Unveiling metabolic remodeling ...... abolomics and pathway analysis

@en

Unveiling metabolic remodeling ...... abolomics and pathway analysis

@nl

prefLabel

Unveiling metabolic remodeling ...... abolomics and pathway analysis

@en

Unveiling metabolic remodeling ...... abolomics and pathway analysis

@nl

P1476

Unveiling metabolic remodeling ...... abolomics and pathway analysis

@en

P2093

Abdellah Tebani

http://www.w3.org/2001/XMLSchema#string

Bruno Gonzalez

http://www.w3.org/2001/XMLSchema#string

Bénédicte Héron

http://www.w3.org/2001/XMLSchema#string

Isabelle Schmitz-Afonso

http://www.w3.org/2001/XMLSchema#string

Lenaig Abily-Donval

http://www.w3.org/2001/XMLSchema#string

Monique Piraud

http://www.w3.org/2001/XMLSchema#string

Stéphane Marret

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical Metabolomics: The New Metabolic Window for Inborn Errors of Metabolism Investigations in the Post-Genomic Era

Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations

'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data

Optimization of a liquid chromatography ion mobility-mass spectrometry method for untargeted metabolomics using experimental design and multivariate data analysis.

Molecular basis of Canavan disease.

Functions of N-acetyl-L-aspartate and N-acetyl-L-aspartylglutamate in the vertebrate brain: role in glial cell-specific signaling.

Mucopolysaccharidosis type IIIB may predominantly present with an attenuated clinical phenotype

The mucopolysaccharidoses: a clinical review and guide to management.

Predicting network activity from high throughput metabolomics.

Modulation of expression of genes involved in glycosaminoglycan metabolism and lysosome biogenesis by flavonoids.

P2888

s12967-018-1625-1

P304

248

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12967-018-1625-1

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-09-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1106595497

http://www.w3.org/2001/XMLSchema#string

P698

30180851

http://www.w3.org/2001/XMLSchema#string

P932

6122730

http://www.w3.org/2001/XMLSchema#string